CD4 and clinically amyopathic dermatomyositis: Suda and his colleagues focused on CADM patients and found that the CD4/CD8 ratio in bronchoalveolar lavage fluid (BALF) was higher in patients with rapidly progressive ILD in comparison to that in chronic ILD patients (45).